Call for Entries: Eppendorf Award 2018!

From October 1, 2017, until January 15, 2018, young researchers not older than 35 years, with an advanced degree, who are working in Europe can apply for the Eppendorf Award for Young European Investigators. This highly prestigious 20,000 EUR prize acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts. The winner is selected by an independent expert committee chaired by Reinhard Jahn (Max Planck Institute for Biophysical Chemistry, Göttingen, Germany). The Award winner 2018 will receive A prize money of 20,000 EUR An invitation to the prize ceremony at the EMBL Advanced Training Centre in Heidelberg, Germany, on June 21, 2018 An invitation to visit Eppendorf AG in Hamburg, Germany Coverage of his/her work by Nature in print and online (including a podcast) Full details on the Eppendorf Award for Young European Investigators, the selection criteria and Award winners since 1995 can be found at www.eppendorf.com/award. Only online applications are accepted. The official online registration portal will accept applications as of October 1, 2017 at www.eppendorf.com/award/application. The Eppendorf award for Young European Investigators is presented in partnership with Nature.

More News

GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)
GQ Bio is pioneering a high-capacity adenovirus (HCAd) gene therapy vector platform that addresses some of the big challenges in the gene therapy field. (Picture: GQ Bio)

Pacira BioSciences Acquires GQ Bio

HTGF portfolio company GQ Bio, pioneering a high-capacity adenovirus gene therapy vector platform, was acquired by Pacira BioSciences, Inc. Pacira, the industry leader in its ...

Read more …
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)
At its new premises in the tecHHub Hamburg, CrystalsFirst is significantly expanding its operations to foster greater synergy. (Picture: CrystalsFirst)

CrystalsFirst Scales Operations...

CrystalsFirst, a leading provider of advanced structural biology solutions and AI-driven drug discovery, is pleased to announce a multi-million-euro expansion of its laboratory infrastructure and ...

Read more …
medac has received FDA approval for treosulfan (Copyright Adobe Stock - Nicolas Hermbach)

Strategic cornerstone for medac: FDA approves treosulfan for alloHSCT

medac has received FDA approval for treosulfan as a new drug application with orphan drug designation prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Read more …